INDP Total Utang marang Modal Indaptus Corp
The historical price chart for the total debt-to-equity ratio of Indaptus Therapeutics (INDP) is 0.00. Indaptus Therapeutics (INDP) implements ESG principles, minimizing environmental impact through the safe recycling of reagents. The operating model relies on external contractors for testing, which eliminates commodity risks. The business develops universal cancer immunotherapy methods, targeting the massive global biotechnology market and leading oncology centers.
Rincian analitis lan laporan data perusahaan Indaptus Corp (INDP)
- rega lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data kapitalisasi buku:
- data utang lan likuiditas:
Utang marang Ekuitas Indaptus Therapeutics|INDP - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Indaptus Therapeutics|INDP - Gunggung utang perusahaan|Utang marang nilai buku Indaptus Therapeutics|INDP - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Indaptus Therapeutics
Analisis komprehensif perusahaan:INDP - Indaptus Therapeutics, Inc.
The ratio determines the proportion of borrowed liabilities to equity, reflecting the extent to which the business's financial stability depends on external lending. By analyzing the current debt load relative to equity through GURU.Markets tools, an investor assesses the risk of default, which is critical for Indaptus Therapeutics (INDP), as its capital-intensive developments in cell immunotherapy and complex certifications require colossal investments.
Pesaing utama
Utang marang Ekuitas argenx ARGX|Utang Agregat marang Ekuitas BioNTech Inc.|Abivax SA (ABVX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ADMA Corp (ADMA)|Total Utang marang Modal PTGX (Protagonist Therapeutics)|immunovant.com - Total Utang marang Modal|Utang marang Ekuitas Kiniksa (KNSA)|GRFS: Rasio Kabeh Utang marang Dana Pribadi|ADPT (Adaptive Biotechnologies Corp) - Utang marang Ekuitas|Celldex Corp (CLDX) - Rasio Total Utang marang Ekuitas|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com (BCRX)|Vera Therapeutics (VERA) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Dianthus Therapeutics Inc (DNTH)|Total Utang marang Modal PHVS|AbCellera - Koefisien Total Utang marang Modal|TRML: Utang marang Ekuitas|PGEN: Rasio Total Utang marang Ekuitas|PHAR (Pharming Group) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ZBIO|Utang marang Ekuitas Immunome, Inc. IMNM|Rasio Utang marang Ekuitas gossamerbio.com (GOSS)|KALV: Total Utang marang Modal|Utang marang Modal Septerna, Inc. SEPN|Total Utang marang Modal PVLA (Pieris Pharmaceuticals Inc)|SVRA: Koefisien Total Utang marang Modal|Utang marang Ekuitas Rigel Pharmaceuticals|anaptysbio.com (ANAB) - Rasio Utang marang Ekuitas|Total Utang marang Modal Astria Therapeutics, Inc. (ATXS)|Rasio Utang marang Ekuitas enGene Holdings Inc|Total Utang marang Modal RAPT|Total Utang marang Modal JBIO (aerovatetx.com)|Aclaris Therapeutics (ACRS) - Utang marang Ekuitas|KYTX - Utang Agregat marang Ekuitas|Rasio Total Utang marang Ekuitas Tiziana Life Sciences Ltd TLSA|Cabaletta Bio Inc. (CABA) - Utang Agregat marang Modal|VTYX: Rasio Total Utang marang Ekuitas|THTX (Theratechnologies, Inc) - Total Utang marang Modal|AVTX: Utang marang Ekuitas|Koefisien Total Utang marang Modal eledon.com (ELDN)|Agenus Inc. (AGEN) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Climb Bio Inc. CLYM|Rasio Total Utang marang Ekuitas Zura Bio Limited (ZURA)|Utang Agregat marang Modal aTyr Pharmaceuticals ATYR|Total Utang marang Modal Adagene Corp (ADAG)|IMA - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal STTK|EQ (Equillium) - Utang marang Modal|CNTB - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Immunic Inc|Total Utang marang Modal ATRA|Total Utang marang Modal IFRX (inflarx.de)|X4 Pharmaceuticals, Inc. (XFOR) - Utang marang Ekuitas|Utang Agregat marang Ekuitas Adicet Bio Inc. ACET|CELU (Celularity Corp) - Total Utang marang Modal|INmune Bio Corporation (INMB) - Utang marang Modal|BRNS: Rasio Total Utang marang Ekuitas|Total Utang marang Modal kezarlifesciences.com|SAB Biotherapeutics, Inc. (SABS) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal Akari Therapeutics PLC|ENLV (Enlivex Therapeutics) - Total Utang marang Modal|Koefisien Total Utang marang Modal q32bio.com (QTTB)|GeoVax Labs, Inc. - Total Utang marang Modal|edesabiotech.com - Rasio Total Utang marang Ekuitas|Utang marang Ekuitas IBIO (iBio)|CARM - Koefisien Total Utang marang Modal|XTL Biopharmaceuticals, Ltd. - Total Utang marang Modal|BOLT (Bolt Biotherapeutics, Inc.) - Koefisien Total Utang marang Modal|Utang marang Ekuitas HCW Biologics, Inc. (HCWB)|Rasio Utang marang Ekuitas Aptevo|Total Utang marang Modal AIM ImmunoTech AIM|Rasio Utang marang Ekuitas ADTX (aditxt.com)|GRI Bio Corp (GRI) - Utang marang Ekuitas|XORTX Corp - Utang Agregat marang Ekuitas|Utang marang Ekuitas Vyome Holdings Inc|REVB - Utang Agregat marang Ekuitas|Total Utang marang Modal Scinai Immunotherapeutics Ltd. SCNI|CalciMedica (CALI) - Rasio Kabeh Utang marang Dana Pribadi|AFMD (Affimed NV) - Total Utang marang Modal|Total Utang marang Modal ALLK|HOOKIPA Pharma Inc. (HOOK) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi IGMS (igmbio.com)|iTeos Therapeutics, Inc. - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Ocean Biomedical Inc OCEA|TC BioPharm (Holdings) PLC - Total Utang marang Modal|Third Harmonic Bio Inc (THRD) - Total Utang marang Modal